DK1791811T3 - Aminoalkoholderivater - Google Patents
AminoalkoholderivaterInfo
- Publication number
- DK1791811T3 DK1791811T3 DK05787773.0T DK05787773T DK1791811T3 DK 1791811 T3 DK1791811 T3 DK 1791811T3 DK 05787773 T DK05787773 T DK 05787773T DK 1791811 T3 DK1791811 T3 DK 1791811T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- hydrogen
- amino alcohol
- alcohol derivatives
- cyclo
- Prior art date
Links
- 150000001414 amino alcohols Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- -1 cyano, carboxy Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004905450A AU2004905450A0 (en) | 2004-09-21 | Aminoalcohol Derivatives | |
AU2005900789A AU2005900789A0 (en) | 2005-02-21 | Aminoalcohol Derivatives | |
PCT/JP2005/017669 WO2006033446A1 (en) | 2004-09-21 | 2005-09-20 | Aminoalcohol derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1791811T3 true DK1791811T3 (da) | 2010-03-22 |
Family
ID=35524070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05787773.0T DK1791811T3 (da) | 2004-09-21 | 2005-09-20 | Aminoalkoholderivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US7928264B2 (da) |
EP (1) | EP1791811B1 (da) |
JP (1) | JP4893620B2 (da) |
KR (1) | KR101052462B1 (da) |
AT (1) | ATE452876T1 (da) |
BR (1) | BRPI0515710A (da) |
CA (1) | CA2580760C (da) |
DE (1) | DE602005018503D1 (da) |
DK (1) | DK1791811T3 (da) |
ES (1) | ES2337164T3 (da) |
IL (1) | IL181888A (da) |
MX (1) | MX2007003111A (da) |
NO (1) | NO20071468L (da) |
PL (1) | PL1791811T3 (da) |
PT (1) | PT1791811E (da) |
RU (1) | RU2399614C2 (da) |
WO (1) | WO2006033446A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100548979C (zh) * | 2007-01-12 | 2009-10-14 | 中国科学院上海有机化学研究所 | 一种合成3-甲氨基吲哚化合物的方法 |
JP6343600B2 (ja) | 2013-02-28 | 2018-06-13 | 武田薬品工業株式会社 | スルホニルクロライド化合物の製造法 |
US11591302B2 (en) | 2014-12-19 | 2023-02-28 | Geistlich Pharm A Ag | Processes for preparing oxathiazin-like compounds |
MX369462B (es) * | 2014-12-19 | 2019-11-08 | Geistlich Pharma Ag | Procedimientos para preparar compuestos de tipo oxatiazina. |
ES2807558T3 (es) * | 2016-04-07 | 2021-02-23 | Geistlich Pharma Ag | Procedimiento de preparación de compuestos de tipo oxatiazina |
EP3538095A4 (en) | 2016-11-14 | 2020-06-17 | Berg LLC | Methods for treating parkinson's disease |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3718638A1 (de) | 1987-06-04 | 1988-12-22 | Thomae Gmbh Dr K | Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
UA58494C2 (uk) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
GT200100147A (es) | 2000-07-31 | 2002-06-25 | Derivados de imidazol | |
GB0021757D0 (en) * | 2000-09-04 | 2000-10-18 | Colaco Camilo | Vaccine against microbial pathogens |
CZ20031012A3 (en) * | 2000-10-20 | 2004-04-14 | Pfizer Products Inc. | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
EP1389185A2 (en) * | 2001-05-24 | 2004-02-18 | Fujisawa Pharmaceutical Co., Ltd. | Aminoalcohol derivatives |
MXPA04012783A (es) * | 2002-06-27 | 2005-02-24 | Fujisawa Pharmaceutical Co | Derivados de aminoalcohol. |
AU2002952839A0 (en) | 2002-11-21 | 2002-12-05 | Fujisawa Pharmaceutical Co., Ltd. | Aminoalcohol derivatives |
WO2005061495A1 (en) * | 2003-12-22 | 2005-07-07 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
WO2005061433A2 (en) | 2003-12-23 | 2005-07-07 | Astellas Pharma Inc. | Aminoalcohol derivatives |
-
2005
- 2005-09-20 CA CA2580760A patent/CA2580760C/en not_active Expired - Fee Related
- 2005-09-20 PT PT05787773T patent/PT1791811E/pt unknown
- 2005-09-20 DK DK05787773.0T patent/DK1791811T3/da active
- 2005-09-20 RU RU2007115092/04A patent/RU2399614C2/ru not_active IP Right Cessation
- 2005-09-20 AT AT05787773T patent/ATE452876T1/de active
- 2005-09-20 JP JP2007512362A patent/JP4893620B2/ja not_active Expired - Fee Related
- 2005-09-20 ES ES05787773T patent/ES2337164T3/es active Active
- 2005-09-20 US US11/547,847 patent/US7928264B2/en not_active Expired - Fee Related
- 2005-09-20 MX MX2007003111A patent/MX2007003111A/es active IP Right Grant
- 2005-09-20 WO PCT/JP2005/017669 patent/WO2006033446A1/en active Application Filing
- 2005-09-20 KR KR1020077006444A patent/KR101052462B1/ko not_active Expired - Fee Related
- 2005-09-20 PL PL05787773T patent/PL1791811T3/pl unknown
- 2005-09-20 EP EP05787773A patent/EP1791811B1/en not_active Not-in-force
- 2005-09-20 BR BRPI0515710-2A patent/BRPI0515710A/pt not_active IP Right Cessation
- 2005-09-20 DE DE602005018503T patent/DE602005018503D1/de active Active
-
2007
- 2007-03-13 IL IL181888A patent/IL181888A/en not_active IP Right Cessation
- 2007-03-19 NO NO20071468A patent/NO20071468L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR101052462B1 (ko) | 2011-07-28 |
KR20070054667A (ko) | 2007-05-29 |
PL1791811T3 (pl) | 2010-06-30 |
IL181888A (en) | 2012-10-31 |
CA2580760C (en) | 2013-08-27 |
BRPI0515710A (pt) | 2008-07-29 |
NO20071468L (no) | 2007-04-20 |
JP2008513348A (ja) | 2008-05-01 |
EP1791811A1 (en) | 2007-06-06 |
CA2580760A1 (en) | 2006-03-30 |
ATE452876T1 (de) | 2010-01-15 |
PT1791811E (pt) | 2010-02-23 |
IL181888A0 (en) | 2007-07-04 |
RU2399614C2 (ru) | 2010-09-20 |
JP4893620B2 (ja) | 2012-03-07 |
EP1791811B1 (en) | 2009-12-23 |
US7928264B2 (en) | 2011-04-19 |
RU2007115092A (ru) | 2008-10-27 |
US20080039506A1 (en) | 2008-02-14 |
ES2337164T3 (es) | 2010-04-21 |
WO2006033446A1 (en) | 2006-03-30 |
MX2007003111A (es) | 2007-05-24 |
DE602005018503D1 (de) | 2010-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200201874T2 (tr) | Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler. | |
EP1248612A4 (en) | NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS | |
WO2002024635A3 (en) | Aminoalcohol derivatives | |
GB0413087D0 (en) | Therapeutic compounds | |
NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
UY27368A1 (es) | Nuevos compuestos | |
RS20050469A (en) | Pyrrolopyrimidine derivatives | |
CY1111693T1 (el) | Αντιιικοι παραγοντες | |
NO20064077L (no) | Kemokinreseptorantagonister | |
AP2001002241A0 (en) | Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents. | |
BG106585A (en) | Kinase inhibitors as therapeutic agents | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
WO2004002939A3 (en) | Aminoalcohol derivatives | |
MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
NO20071468L (no) | Aminoalcohol derivatives | |
BRPI0409959A (pt) | uso de derivados de azetidinacarboxamida em terapia | |
NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
PT992509E (pt) | Novos derivados macrolidos | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
SE0102440D0 (sv) | New compound | |
WO2002094770A3 (en) | Aminoalcohol derivatives | |
IL160082A0 (en) | Quinoline derivatives and use thereof as antitumor agents | |
ATE308540T1 (de) | Antithrombosemittel | |
EP1679304A4 (en) | AMINO ALCOHOL DERIVATIVE, MEDICAL COMPOSITION CONTAINING THEREOF AND ITS USE | |
WO2005061433A3 (en) | Aminoalcohol derivatives |